Abbott Cuts Guidance After Exact Sciences Split
Abbott Laboratories revised its financial guidance downward following the unwinding of its relationship with Exact Sciences, sending shares sharply lower. The guidance cut raises fresh concerns about near-term revenue visibility in Abbott's diagnostics segment. Analysts are likely to revise forward estimates pending